Proteomic analysis of the trabecular meshwork of rats in a steroid-induced ocular hypertension model: Downregulation of type I collagen C-propeptides

Ophthalmic Research

Volumn 39, Issue 6, 2007, Pages 330-337

  Shinzato, Manabu ^a   Yamashiro, Yoshito ^a   Miyara, Nariko ^a   Iwamatsu, Akihiro ^b   Takeuchi, Kouji ^c   Umikawa, Masato ^a   Bayarjargal, Maitsetseg ^a   Kariya, Ken Ichi ^a   Sawaguchi, Shoichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Protein Research Network Inc   (Japan)

^c DNA BANK Co Ltd   (Japan)

Author keywords

Proteomics; Rat steroid induced ocular hypertensive model; Trabecular meshwork

Indexed keywords

ALPHA CRYSTALLIN; COLLAGEN TYPE 1; DEXAMETHASONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GEL ELECTROPHORESIS; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; RAT; TONOMETER; TRABECULAR MESHWORK; UPREGULATION;

ALPHA-CRYSTALLIN A CHAIN; ANIMALS; COLLAGEN TYPE I; CRYSTALLINS; DEXAMETHASONE; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUCOCORTICOIDS; INTRAOCULAR PRESSURE; MALE; MASS SPECTROMETRY; OCULAR HYPERTENSION; PROTEIN PRECURSORS; PROTEOMICS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRABECULAR MESHWORK; UP-REGULATION;

EID: 36949040162     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109989     Document Type: Article

References (32)

1. Knepper PA, Collins JA, Frederick R: Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest Ophthalmol Vis Sci 1985;26:1093-1100.
2. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD: Dexamethasone induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci 1995;36:478-489.
3. Gelatt KN, Mackay EO: The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma. J Ocular Pharmacol Ther 1998;14:57-66.
4. Kass MA, Johnson T: Corticosteroid-induced glaucoma; in Ritch R, Shields MB, Krupin T (eds): The Glaucomas. St Louis, Mosby, 1989, vol 2, pp 1161-1168.
5. Lutjen-Drecoll E: Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res 1999;18:91-119.
6. Lutjen-Drecoll E: Importance of trabecular meshwork changes in the pathogenesis of primary open-angle glaucoma. J Glaucoma 2000;9:417-418.
7. Johnson D, Gottanka J, Flugel C, Hoffman F, Futa R, Lutjen-Drecoll E: Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997;115:375-383.
8. Alvarado JA, Yun AJ, Murphy CG: Juxtacanalicular tissue in primary open angle glaucoma and in nonglaucomatous normals. Arch Ophthalmol 1986;104:1517-1528.
9. Kersey JP, Broadway DC: Corticosteroid-induced glaucoma: a review of the literature. Eye 2006;20:407-416.
10. Polansky JR, Fauss DJ, Chen P, Chen H, Lutjen-Dercoll E, Johnson D, Kurtz RM, Ma ZD, Bloom E, Nguyen TD: Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 1997;211:126-139.
11. Wang X, Johnson DH: mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork. Invest Ophthalmol Vis Sci 2000;41:1724-1729.
12. Clark AF, Steely HT, Dickerson JE Jr, English-Wright S, Stropki K, McCartney MD, Jacobson N, Shepard AR, Clark JI, Matsushima H, Peskind ER, Levernz JB, Wilkinson CW, Swiderski RE, Fingert JH, Sheffield VC, Stone EM: Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci 2001;42:1769-1780.
13. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nicols BE, Mackey DA, Ritch R, Kalenlak JW, Craven ER, Sheffield VC: Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668-670.
14. Alward WL, Fingert JH, Coote MA, Johnson AT, Lerner SF, Junqua D, Durcan FJ, McCartney PJ, Mackey DA, Sheffield VC, Stone EM: Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998;338:1022-1027.
15. Gould DB, Miceli-Libby L, Savinova OV, Torrado M, Tmarev SI, Smith RS, John SW: Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol 2004;24:9019-9025.
16. Sawaguchi K, Nakamura Y, Nakamura Y, Sakai H, Sawaguchi S: Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model. Ophthalmic Res 2005;37:235-242.
17. Pandey A, Mann M: Proteomics to study gene and genomes. Nature 2000;405:837-846.
18. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, Timms JF: Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 2002;1:91-98.
19. Iwamatsu A: S-carboxymethylation of proteins transferred onto polyvinylidene difluoride membranes followed by in situ protease digestion and amino acid microsequencing. Electrophoresis 1992;13:142-147.
20. Jensen ON, Podtelejnikov A, Mann M: Delayed extraction improves specificity in database searches by matrix-assisted laser desorption/ionization peptide maps. Rapid Commun Mass Spectrom 1996;10:1371-1378.
21. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R: A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 1995;130:227-237.
22. Aihara M, Lindsey JD, Weinreb RN: Ocular hypertension in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci 2003;44:1581-1585.
23. Canty EG, Kadler KE: Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 2005;118:1341-1353.
24. Melkko J, Niemi S, Risteli L, Risteli J: Radio-immunoassay of the carboxyterminal propeptide of human type 1 procollagen. Clin Chem 1990;36:1328-1332.
25. Steiglitz BM, Keene DR, Greenspan DS: PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1. J Biol Chem 2002;277:49820-49830.
26. Bhattacharya SK, Rockwood EJ, Smith SD, Bonilha VL, Crabb JS, Kuchtey RW, Robertson NG, Peachey NS, Morton CC, Crabb JW: Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem 2005;280:6080-6084.
27. Zhou L, Li Y, Yue BY: Glucocorticoid effects on extracellular matrix proteins and integrins in bovine trabecular meshwork cells in relation to glaucoma. Int J Mol Med 1998;1:339-346.
28. Andley UP: Crystallins in the eye: function and pathology. Prog Retin Eye Res 2007;26:78-98.
29. Augusten RC: Alpha crystallin: a review of its structure and function. Clin Exp Optom 2004;87:356-366.
30. Xi J, Farjo R, Yoshida S, Kern T, Swroop A, Andley UP: A comprehensive analysis of the expression of crystallins in mouse retina. Mol Vis 2003;9:410-419.
31. Lampi KJ, Shih M, Ueda Y, Shearer TR, David LL: Lens proteomics: analysis of rat crystallin sequences and two-dimensional electrophoresis map. Invest Ophthalmol Vis Sci 2002;43:216-224.
32. Wistow GJ, Piatigorsky J: Lens crystallins: the evolution and expression of proteins for a highly specialized tissue. Annu Rev Biochem 1988;57:479-504.